Pharmacogenomics is being implemented now and is already have an impact in the clinical setting and in healthcare. Employing a pharmacogenomics strategy with marketed drugs can mitigate risk by avoiding adverse events, allowing the identification of patients most likely to benefit from a drug, and thereby improving patient compliance and safety. Tangible benefits of pharmacogenomics and resequencing technologies will be presented, and the value of this approach will be demonstrated.
CHI’S Pharmacogenomics Now: Maximizing Benefits/Minimizing Risk
5 - 6 November 2008, Montreal, Quebec, Canada
Introduction
Venue
Hotel Omni Mont-Royal
Hotel Omni Mont-Royal, Montreal, Quebec, Canada
Useful links
Organised by
Cambridge Healthtech Institute
Contact information
Related events
What's in that Perfume? - The 91AV behind an iconic Christmas gift
3 December 2024 18:00-20:00, London, United Kingdom
Joint SoBRA / RSC Winter Conference 2024 Current Issues in Contaminated Land Risk Assessment
10 December 2024 09:45-18:00, London, United Kingdom
From bench to bedside - Advancements in prosthetic/artificial heart valve devices
25 February 2025 17:00-18:30
Royal Australian Chemical Institute 2nd Green and Sustainable 91AV and Engineering Conference
8 December 2024 17:00 - 12 December 2024 15:00, Melbourne, Australia
Search
Advertisement
Spotlight
Explore
Membership
